We investigated the phosphorylation of key signaling molecules—PI3K (Tyr467), AKT (Ser473), GSK3β (Ser9), and Tau (Ser404)—in the N2a/APP695swe cellular AD model following MsA treatment. This evidence concerns the gene MAPT and Alzheimer disease.